La Haute autorit\u00e9 de sant\u00e9 (HAS) a donn\u00e9 ce vendredi 21 janvier 2022, son feu vert \u00e0 l’utilisation de l’antiviral Paxlovid comme traitement curatif contre le Covid 19, dont les premi\u00e8res livraisons sont attendues en France d’ici quelques jours.<\/p>\n\n\n\n
Suite \u00e0 l’avis de l’agence nationale du m\u00e9dicament, la HAS \u00abautorise l’acc\u00e8s pr\u00e9coce au traitement Paxlovid (nirmatrelvir\/ritonavir) du laboratoire Pfizer pour les adultes atteints de Covid-19 ne n\u00e9cessitant pas d’oxyg\u00e9noth\u00e9rapie et \u00e0 risque \u00e9lev\u00e9 d’\u00e9volution vers une forme grave de la maladie\u00bb. Il s’agit d’un traitement avant tout destin\u00e9 aux populations \u00e0 risque (personnes tr\u00e8s \u00e2g\u00e9es, immunod\u00e9prim\u00e9es, atteintes de certaines maladies rares…)<\/p>\n","protected":false},"excerpt":{"rendered":"
La Haute autorit\u00e9 de sant\u00e9 (HAS) a donn\u00e9 ce vendredi 21 janvier 2022, son feu vert \u00e0 l’utilisation de l’antiviral Paxlovid comme traitement curatif contre le Covid 19, dont les premi\u00e8res livraisons sont attendues en France d’ici quelques jours. Suite \u00e0 l’avis de l’agence nationale du m\u00e9dicament, la HAS \u00abautorise l’acc\u00e8s pr\u00e9coce au traitement Paxlovid […]<\/p>\n","protected":false},"author":4,"featured_media":36708,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"content-type":"","jnews-multi-image_gallery":[],"jnews_single_post":{"subtitle":"","format":"standard"},"jnews_primary_category":[],"jnews_override_bookmark_settings":[],"jnews_review":[],"enable_review":"","type":"","name":"","summary":"","brand":"","sku":"","good":[],"bad":[],"score_override":"","override_value":"","rating":[],"price":[],"jnews_post_split":[],"footnotes":""},"categories":[6],"tags":[],"class_list":["post-36707","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-world"],"_links":{"self":[{"href":"https:\/\/www.africanchallenges.com\/index.php?rest_route=\/wp\/v2\/posts\/36707","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.africanchallenges.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.africanchallenges.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.africanchallenges.com\/index.php?rest_route=\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.africanchallenges.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=36707"}],"version-history":[{"count":1,"href":"https:\/\/www.africanchallenges.com\/index.php?rest_route=\/wp\/v2\/posts\/36707\/revisions"}],"predecessor-version":[{"id":36709,"href":"https:\/\/www.africanchallenges.com\/index.php?rest_route=\/wp\/v2\/posts\/36707\/revisions\/36709"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.africanchallenges.com\/index.php?rest_route=\/wp\/v2\/media\/36708"}],"wp:attachment":[{"href":"https:\/\/www.africanchallenges.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=36707"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.africanchallenges.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=36707"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.africanchallenges.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=36707"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}